Results 111 to 120 of about 20,082,992 (152)

Pathology-guided enrichment of targetable gene rearrangements in BRAF wild-type papillary thyroid carcinoma. [PDF]

Sci Rep
Jin M, Kim CA, Jeon MJ, Lee YM, Sung TY, Kim TY, Song DE, Kim WG.   +7 more
europepmc   +1 more source

Research progress of small molecule targeted drugs for non-small cell lung cancer. [PDF]

Front Oncol
Qiu T, Huang X.
europepmc   +1 more source

Dual targeting of RET and SRC synergizes in RET fusion-positive cancer cells. [PDF]

Mol Oncol
Son J, Remsing Rix LL, Fang B, Welsh EA, Bremer NV, Foglizzo V, Roa P, Sigcha-Coello N, Liao Y, Haura EB, Drilon A, Koomen JM, Cocco E, Rix U.   +13 more
europepmc   +1 more source

Resistance to third-generation EGFR TKIs - what can be expected from the fourth-generation? [PDF]

Cancer Drug Resist
Dempke WCM, Fenchel K, Sullivan L, Reck M.   +3 more
europepmc   +1 more source

The Role of KRAS in Non-Small Cell Lung Cancer: From Molecular Background to Precision Medicine. [PDF]

Int J Mol Sci
Gaździcka J, Gołąbek K.
europepmc   +1 more source

Selpercatinib versus multi-kinase inhibitors for advanced medullary thyroid cancer: A network meta-analysis of RET-targeted therapies. [PDF]

Front Endocrinol (Lausanne)
Wang J, Cao G, Liu Y, Qiao H, He Q, Zheng B.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Diversity of mutations in the RET proto-oncogene and its oncogenic mechanism in medullary thyroid cancer

Critical Reviews in Clinical Laboratory Sciences, 2016
Mehdi Hedayati, Marjan Zarif Yeganeh
exaly   +2 more sources

RET proto-oncogene testing in infants presenting with Hirschsprung disease identifies 2 new multiple endocrine neoplasia 2A kindreds

Journal of Pediatric Surgery, 2008
Mary K Debenedetti, Jeffrey F Moley
exaly   +2 more sources

Optimized efficient screening for Duchenne muscular dystrophy carriers using proto-oncogene tyrosine-protein kinase receptor Ret.

Laboratoriums Medizin
INTRODUCTION Duchenne muscular dystrophy (DMD) is a severe genetic disorder affecting 5% to 19% of carriers. Creatine kinase (CK) is a traditional biomarker for DMD, but its screening accuracy is limited.
D. Hong, Zhilei Zhang, Yun Sun, Xin Wang, Peiying Yang, Tao Jiang, Bin Yu   +6 more
semanticscholar   +1 more source

Activation of the mTOR pathway in primary medullary thyroid carcinoma and lymph node metastases.

Journal of Clinical Oncology, 2011
Anna Tamburrino, A. Molinolo, P. Salerno, R. Chernock, M. Raffeld, Liqiang Xi, J. Gutkind, J. Moley, Samuel A. Wells, M. Santoro   +9 more
semanticscholar   +1 more source